Rationale of Technical Requirements for NRG-BR001: The First NCI-Sponsored Trial of SBRT for the Treatment of Multiple Metastases

INTRODUCTION: In 2014, the NRG Oncology Group initiated the first NCI-sponsored, phase I clinical trial of SBRT for the treatment of multiple metastases in multiple organ sites (XXXX; NCTXXX). The primary endpoint is to test the safety of SBRT for the treatment of multiple lesions (2–4) in several a...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Pract Radiat Oncol
Hoofdauteurs: Al-Hallaq, Hania A, Chmura, Steven, Salama, Joseph K, Winter, Kathryn A, Robinson, Clifford G, Pisansky, Thomas M, Borges, Virginia, Lowenstein, Jessica L, McNulty, Susan, Galvin, James M, Followill, David S, Timmerman, Robert D, White, Julia R, Xiao, Ying, Matuszak, Martha M
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2016
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5099083/
https://ncbi.nlm.nih.gov/pubmed/27345129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prro.2016.05.004
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items